Explore Watchlists Pricing

Shionogi & Co.,Ltd. (4507) Income statement

Market cap

¥2.53T

P/E ratio

11.5x

Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	267,275	282,903	289,717	273,991	309,973	338,890	344,667	363,721	334,958	297,177	335,138	426,684	410,073	438,268	499,677
Revenue growth (%)	-
Cost of revenue	-	-	-	82,189	74,758	77,777	73,911	54,880	56,782	52,523	55,415	62,246	57,602	63,826	82,450
Gross profit	-	-	-	191,801	235,214	261,113	270,756	308,841	276,589	244,654	279,722	364,437	377,479	374,441	417,226
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	141,436	143,808	152,934	155,537	170,303	95,094	91,902	91,771	97,775	99,651	101,873	126,905
Operating income	-	-	-	50,365	91,406	108,178	115,219	138,537	130,628	117,438	110,312	149,003	153,310	156,603	133,261
Income before tax	46,093	58,922	62,225	77,880	100,869	123,031	138,692	166,575	158,516	143,018	126,268	220,332	198,283	200,750	138,315
Pretax margin (%)	17.2	20.8	21.5	28.4	32.5	36.3	40.2	45.8	47.3	48.1	37.7	51.6	48.4	45.8	27.7
Provision for income taxes	-	-	-	37,832	30,824	39,084	28,589	37,037	36,322	30,956	12,829	35,836	37,708	31,215	33,002
Effective tax rate (%)	-	-	-
Net income	43,678	-32,014	54,600	44,218	66,687	83,879	108,866	133,306	122,193	111,858	114,185	184,965	162,030	170,435	138,883
Earnings per share	80.93	199.25	121.29	132.67	204.83	259.88	342.71	424.31	395.71	365.03	378.75	621.31	558.51	200.36	161.51
Diluted EPS	80.91	199.17	121.23	132.04	201.7	255.87	337.43	420.67	395.28	364.89	378.63	621.1	558.32	200.29	241.04
Dividend payout ratio (%)	-	-	-	-	-	-	-	-						-
Dividend per share	-	-	-	-	-	-	-	-	103	108	115	135	160	-	71